N335649
HTS 3002150011
The tariff classification of Hyrimoz® (adalimumab-adaz) Injection in dosage form, from Austria
Reasoning
The tariff classification of Hyrimoz® (adalimumab-adaz) Injection in dosage form, from Austria
Cite this ruling
CBP Ruling N335649 (3002150011): The tariff classification of Hyrimoz® (adalimumab-adaz) Injection in dosage form, from Austria
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300215
The tariff classification of HEC88473 Drug Product (also known as APL-18881) in dosage form, from China
The tariff classification of clinical trial kits from the United States
The tariff classification of various recombinant proteins packed for retail sale from India
The tariff classification of HRP Conjugated antibodies from India
The tariff classification of polyclonal rabbit antibodies from India